Comparison of estimated human dose of 68Ga-MAA with 99mTc-MAA based on rat data

详细信息    查看全文

• 作者：Saeed Shanehsazzadeh ; Afsaneh Lahooti ; Hassan Yousefnia…
• 关键词：Biodistribution ; Effective absorbed dose ; Gallium 68 ; Macroaggregated albumin (MAA)
• 刊名：Annals of Nuclear Medicine
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：29
• 期：8
• 页码：745-753
• 全文大小：738 KB
• 参考文献：1.Velikyan I. Prospective of 68Ga-radiopharmaceutical development. Theranostics. 2014;4:47鈥?0.PubMed Central CrossRef
  2.Jalilian AR, Shanesazzadeh S, Rowshanfarzad P, Bolourinovin F, Majdabadi A. Biodistribution study of [61 Cu] pyruvaldehyde-bis (N-4-methylthiosemicarbazone) in normal rats as a PET tracer. Nucl Sci Tech. 2008;19:159鈥?4.CrossRef
  3.Firestone RB, Shirley VS. Table of Isotopes, 2 Volume Set. In: Firestone RB, Shirley VS, editors. p. 3168. ISBN 0-471-33056-6 Wiley; 1998. p. 1.
  4.Roesch F, Riss J. P. The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry. Curr Top Med Chem. 2010;10:1633鈥?8.CrossRef PubMed
  5.Yang DJ, Kim EE, Inoue T. Targeted molecular imaging in oncology. Ann Nucl Med. 2006;20(1):1鈥?1.CrossRef PubMed
  6.Shanehsazzadeh S, Yousefnia H, Jalilian A, Zolghadri S, Lahooti A. Estimated human absorbed dose for 68Ga-ECC based on mice data: comparison with 67Ga-ECC. Ann Nucl Med. 2015. doi:10.鈥?007/鈥媠12149-015-0967-5 .
  7.De Queir贸s A, Brand茫o S, Macedo L, Ourem M, Mota V, Leite L, et al. Evaluation of normality and reproducibility parameters of scintigraphy with 99mTc-MAA in the diagnosis of intrapulmonary vascular dilatations. Ann Nucl Med. 2015;29:46鈥?1.CrossRef PubMed
  8.Mahdavi R, Caronia J, Fayyaz J, Panagopoulos G, Lessnau K, Scharf S, et al. Agreement between SPECT V/Q scan and CT angiography in patients with high clinical suspicion of PE. Ann Nucl Med. 2013;27:834鈥?.CrossRef PubMed
  9.Even GA, Green MA. Gallium-68-labeled macroaggregated human serum albumin, 68Ga-MAA. Int J Rad Appl Instrum B. 1989;16:319鈥?1.CrossRef PubMed
  10.Shanehsazzadeh S, Lahooti A, Shirmardi SP, Erfani M. Comparison of estimated human effective dose of 67Ga-and 99mTc-labeled bombesin based on distribution data in mice. J Radioanal Nucl Chem. 2015. doi:10.鈥?007/鈥媠10967-015-3995-7 .
  11.Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023鈥?.PubMed
  12.Snyder W, Ford M, Warner G, Watson S. S鈥?absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11. Society of Nuclear Medicine, New York. 1975.
  13.Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:37S鈥?1S.PubMed
  14.Shanehsazzadeh S, Yousefnia H, Lahooti A, Zolghadri S, Jalilian AR, Afarideh H. Assessment of human effective absorbed dose of 67Ga鈥揈CC based on biodistribution rat data. Ann Nucl Med. 2014;29:118鈥?4.CrossRef PubMed
  15.Sadeghzadeh M, Shanehsazzadeh S, Lahooti A. Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl) piperidine in humans on the basis of biodistribution data of rats. Nucl Med Commun. 2015;36:90鈥?.CrossRef PubMed
  16.Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. In: Sixth international radiopharmaceutical dosimetry symposium oak ridge. Oak Ridge Associated Universities; 1996. p. 705鈥?6.
  17.Maus S, Buchholz H-G, Ament S, Brochhausen C, Bausbacher N, Schreckenberger M. Labelling of commercially available human serum albumin kits with 68Ga as surrogates for 99mTc-MAA microspheres. Appl Radiat Isotop. 2011;69:171鈥?.CrossRef
  18.Council B. Guidelines on the use of living animals in scientific investigations. Biological council. 1987.
  19.Amor-Coarasa A, Milera A, Carvajal DA, McGoron AJ, editors. 99mTc-MAA vs. 68Ga-MAA as Perfusion Agents. Biomedical Engineering Conference (SBEC), 2013 29th Southern; 2013: IEEE.
  20.Lahooti A, Shanehsazzadeh S, Jalilian AR, Tavakoli MB. Assessment of effective absorbed dose of 111In-DTPA-Buserelin in human on the basis of biodistribution rat data. Radiat Prot Dosim. 2013;154:1鈥?.CrossRef
  21.Shanehsazzadeh S, Lahooti A. Biodistribution of 80聽nm iron oxide nanoparticles labeled with 99mTc in Balb/c mice. Nucl Med Biol. 2014;41:625.CrossRef
  22.Shanehsazzadeh S, Oghabian MA, Lahooti A, Abdollahi M, Haeri SA, Amanlou M, et al. Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers. Nucl Med Commun. 2013;34:915鈥?5.PubMed
  23.Jalilian A, Shanehsazzadeh S, Akhlaghi M, Garoosi J, Rajabifar S, Tavakoli M. Preparation and evaluation of [67Ga]-DTPA-尾-1鈭?4-corticotrophin in normal rats. Radiochim Acta. 2008;96:435鈥?.
  24.Jalilian A, Shanehsazzadeh S, Akhlaghi M, Kamali-Dehghan M, Moradkhani S. Development of [111In]-DTPA-buserelin for GnRH receptor studies. Radiochim Acta. 2010;98:113鈥?.
  25.Moghaddam AK, Jalilian AR, Hayati V, Shanehsazzadeh S. Determination of human absorbed dose of 201Tl (III)-DTPA-HIgG based on biodistribution data in rats. Radiat Prot Dosim. 2010;141:269鈥?4.CrossRef
  26.Lahooti A, Shanehsazzadeh S, Oghabian MA, Allen BJ. Assessment of human effective absorbed dose of Tc-99m-USPIO based on biodistribution rat data. J Labelled Compd Radiopharm. 2013;56:S258.
  27.Shanehsazzadeh S, Oghabian MA, Lahooti A, Allen BJ. Development of ultra small super paramagnetic iron oxide nanoparticles labeled with Gallium 67 as a dual modality probe. J Labelled Compd Radiopharm. 2013;56:S236.
  28.Moghaddam AK, Jalilian AR, Hayati V, Shanehsazzadeh S, Dodangeh A. Evaluation And Calculation of Human absorbed dose of (201) Tl(III)-DTPA-HIgG based on biodistribution data in rats. J Labelled Compd Radiopharm. 2011;54:S347.
  29.Jalilian A, Shanehsazzadeh S, Akhlaghi M, Garousi J, Rajabifar S, Tavakoli M. Preparation and biodistribution of [67 Ga]-DTPA-gonadorelin in normal rats. J Radioanal Nucl Chem. 2008;278:123鈥?.CrossRef
  30.Shanehsazzadeh S, Jalilian AR, Sadeghi HR, Allahverdi M. Determination of human absorbed dose of 67Ga-DTPA-ACTH based on distribution data in rats. Radiat Prot Dosim. 2009;134:79鈥?6.CrossRef
  31.Shanehsazzadeh S, Lahooti A, Sadeghi HR, Jalilian AR. Estimation of human effective absorbed dose of 67Ga鈥揷DTPA鈥揼onadorelin based on biodistribution rat data. Nucl Med Commun. 2011;32:37鈥?3.CrossRef PubMed
  32.Bevelacqua J. Internal dosimetry primer. Radiat Prot. Manage. 2005;22:7鈥?7.
  33.Icrp. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Ann ICRP. 2008;38:1鈥?97.
  34.Oghabian MA, Gharehaghaji N, Masoudi A, Shanehsazzadeh S, Ahmadi R, Majidi RF, et al. Effect of coating materials on lymph nodes detection using magnetite nanoparticles. Adv Sci Eng Med. 2013;5:37鈥?5.CrossRef
  35.Omid H, Oghabian MA, Ahmadi R, Shahbazi N, Hosseini HRM, Shanehsazzadeh S, et al. Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation. BBA Gen Subj. 2014;1840:428鈥?3.CrossRef
  36.Mirzaei A, Jalilian A, Aghanejad A, Mazidi M, Yousefnia H, Shabani G, et al. Preparation and evaluation of 68Ga-ECC as a PET renal imaging agent. Nucl Med Mol Imag. 2015. doi:10.鈥?007/鈥媠13139-015-0323-7 .
  37.Shanehsazzadeh S, Oghabian MA, Daha FJ, Amanlou M, Allen BJ. Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice. J Radioanal Nucl Chem. 2013;295:1517鈥?3.CrossRef
  38.Shanehsazzadeh S, Gruettner C, Lahooti A, Mahmoudi M, Allen BJ, Ghavami M, et al. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo. Contrast Media Mol Imaging. 2015;10:225鈥?6.CrossRef PubMed
  39.Wild D, Wicki A, Mansi R, B茅h茅 M, Keil B, Bernhardt P, et al. Exendin-4鈥揃ased Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT. J Nucl Med. 2010;51:1059鈥?7.CrossRef PubMed
  40.Etchebehere ECSdC, de Oliveira Santos A, Gumz B, Vicente A, Hoff PG, Corradi G, et al. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-Octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial. J Nucl Med. 2014;55:1598鈥?04.
  41.Wu SY, Kuo JW, Chang TK, Liu RS, Lee RC, Wang SJ, et al. Preclinical characterization of 18F-MAA, a novel PET surrogate of 99mTc-MAA. Nucl Med Biol. 2012;39:1026鈥?3.CrossRef PubMed
  
• 作者单位：Saeed Shanehsazzadeh (1)
  Afsaneh Lahooti (2)
  Hassan Yousefnia (1)
  Parham Geramifar (3)
  Amir Reza Jalilian (1)
  
  1. Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), P. O. Box: 11365-3486, Tehran, Iran
  2. Department of Medical Physics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. Research Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  
• 刊物主题：Nuclear Medicine; Imaging / Radiology;
• 出版者：Springer Japan
• ISSN：1864-6433

文摘

Objective 99mTc macroaggregated albumin (99mTc-MAA) that had been used as a perfusion agent has been evaluated. In this study, we tried to estimate human absorbed dose of 68Ga-MAA via commercially available kit from Pars-Isotopes, based on biodistribution data in wild-type rats, and compare our estimation with the available absorbed dose data from 99mTc-MAA.